| Structure | Chemical Name | CAS | MF |
|
Mannotriose-(fucosyl-di-(N-acetyl-*gucos amine)), mo
|
571188-30-2
|
C79H131N5O58
|
|
tert-butyl 4-(6-aminopyridin-3-yl)piperazine-1-carboxylate
|
571188-59-5
|
C14H22N4O2
|
|
6-BroMo-8-cyclopentyl-2-Methanesulfinyl-5-Methyl-8H-pyrido[2,3-d]pyriMidin-7-one
|
571188-81-3
|
C14H16BrN3O2S
|
|
tert-Butyl 4-(6-(6-bromo-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydro-pyrido(2,3-d)pyrimidin-2-ylamino)-pyridin-3-yl)-piperazine-1-carboxylate
|
571188-82-4
|
C27H34BrN7O3
|
|
Pyrido[2,3-d]pyriMidine-6-carboxylic acid, 8-cyclopentyl-2-[[5-[4-[(1,1-diMethylethoxy)carbonyl]-1-piperazinyl]-2-pyridinyl]aMino]-7,8-dihydro-5-Methyl-7-oxo-, ethyl ester
|
571189-03-2
|
C30H39N7O5
|
|
4-{6-[8-Cyclopentyl-6-(1-ethoxy-vinyl)-5-methyl-7-oxo-7,8-dihydro-pyrido[2,3-d]pyrimidin-2-ylamino]-pyridin-3-yl}-piperazine-1-carboxylic acid tert-butyl ester
|
571189-10-1
|
C31H41N7O4
|
|
6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one hydrochloride
|
571189-11-2
|
C24H30ClN7O2
|
|
Tert-butyl 4-(6-nitropyridin-3-yl)piperazine-1-carboxylate
|
571189-16-7
|
C14H20N4O4
|
|
1-Boc-4-(2-amino-4-pyridinyl)-piperazine
|
571189-23-6
|
C14H22N4O2
|
|
Pyrido[2,3-d]pyrimidin-7(8H)-one, 8-cyclopentyl-6-ethyl-2-(methylsulfonyl)-
|
571189-26-9
|
C15H19N3O3S
|
|
5-(4-Methylpiperazin-1-yl)pyridin-2-amine
|
571189-49-6
|
C10H16N4
|
|
Palbociclib Impurity 87
|
571189-51-0
|
C25H31N7O2
|
|
4-[6-[(8-Cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino]pyridin-3-yl]piperazine-1-carboxylic acid tert-butyl ester
|
571189-65-6
|
C27H35N7O3
|
|
Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-, hydrochloride (1:)
|
571189-66-7
|
C22H28ClN7O
|
|
5-morpholinopyridin-2-amine
|
571189-78-1
|
C9H13N3O
|
|
Pyrido[2,3-d]pyriMidin-7(8H)-one, 8-cyclopentyl-5-Methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]aMino]-
|
571190-22-2
|
C22H27N7O
|
|
Palbociclib
|
571190-30-2
|
C24H29N7O2
|
|
1H,3H-Pyrrolo[1,2-c]oxazol-3-one,5,7a-dihydro-,(7aS)-(9CI)
|
571201-15-5
|
C6H7NO2
|
|
(3-Bromophenoxy)triisopropylsilane 97
|
571202-87-4
|
C15H25BrOSi
|
|
Erastin
|
571203-78-6
|
C30H31ClN4O4
|
|
6-Hydroxynaphthalene-1-carboxaldehyde
|
571206-45-6
|
C11H8O2
|
|
3-tert-butyl-5-(4-methoxyphenyl)-9-methylfuro[3,2-g]chromen-7-one
|
571207-68-6
|
C23H22O4
|
|
3-(phenylamino)benzonitrile
|
571903-59-8
|
C13H10N2
|
|
6-Quinoxalinecarboxamide,N-cyclohexyl-(9CI)
|
571910-75-3
|
C15H17N3O
|
|
6-Quinoxalinecarboxamide,N-2-thiazolyl-(9CI)
|
571910-89-9
|
C12H8N4OS
|
|
3-Pyridinecarboxamide,N-cyclopentyl-2-(1-pyrrolidinyl)-(9CI)
|
571912-41-9
|
C15H21N3O
|
|
3-Pyridinecarboxylicacid,2-(3-methyl-1-piperidinyl)-(9CI)
|
571912-85-1
|
C12H16N2O2
|
|
2-Azepan-1-yl-nicotinic acid
|
571913-22-9
|
C12H16N2O2
|
|
3-Pyridinecarboxamide,N-cyclopentyl-6-(1-pyrrolidinyl)-(9CI)
|
571914-86-8
|
C15H21N3O
|
|
3-Pyridinecarboxylicacid,6-(cyclopentylamino)-(9CI)
|
571915-69-0
|
C11H14N2O2
|
|
N-(6-Amino-1-butyl-2,4-dioxo-1,2,3,4-tetrahydro-pyrimidin-5-yl)-2-chloro-N-(2-methoxy-ethyl)-acetamide
|
571917-24-3
|
C13H21ClN4O4
|
|
8-Chloro-6-(trifluoromethyl)[1,2,4]triazolo[4,3-a]pyridine-3-thiol
|
571917-27-6
|
C7H3ClF3N3S
|
|
2-Chloro-N-(2-chloro-4-Methylphenyl)benzaMide, 97%
|
571918-80-4
|
C14H11Cl2NO
|
|
2-Propenoicacid,2-cyano-3-(4-ethoxyphenyl)-(9CI)
|
571919-28-3
|
C12H11NO3
|
|
3-Methoxy-4-propoxy-benzaldehyde oxime
|
571920-77-9
|
C11H15NO3
|
|
1H-Pyrrole-3-carboxylicacid,2,4-dimethyl-5-[(2-methyl-1-oxopropoxy)acetyl]-,ethylester(9CI)
|
571922-51-5
|
C15H21NO5
|
|
1H-Pyrrole-3-carboxylicacid,5-[[(ethoxyacetyl)oxy]acetyl]-2,4-dimethyl-,ethylester(9CI)
|
571922-83-3
|
C15H21NO6
|
|
1H-Pyrrole-2,4-dicarboxylicacid,3,5-dimethyl-,4-(3,3-dimethyl-2-oxobutyl)2-ethylester(9CI)
|
571922-93-5
|
C16H23NO5
|
|
1H-Pyrrole-3-carboxylicacid,2,4-dimethyl-5-[[(1-oxo-2-butenyl)oxy]acetyl]-,ethylester(9CI)
|
571923-60-9
|
C15H19NO5
|
|
1H-Pyrrole-2,4-dicarboxylicacid,3,5-dimethyl-,2-ethyl4-[2-[(1-methylethyl)amino]-2-oxoethyl]ester(9CI)
|
571926-41-5
|
C15H22N2O5
|
|
Benzamide, N-(5-cyclopropyl-1,3,4-thiadiazol-2-yl)-3-methyl- (9CI)
|
571954-81-9
|
C13H13N3OS
|
|
7-Oxabicyclo[4.1.0]heptan-3-ol,6-methyl-3-(1-methylethyl)-,(3S)-(9CI)
|
572874-45-4
|
C10H18O2
|
|
MK 0524 sodium salt
|
572874-50-1
|
C21H20ClFNNaO4S
|
|
3-Chloro-N-[4-(2-oxopyrrolidin-1-yl)phenyl]propanamide
|
572882-25-8
|
C9H10ClNO3S
|
|
(2 3-Difluorophenyl)thiourea 97
|
572889-25-9
|
C7H6F2N2S
|
|
3-methylimidazo[1,2-b]pyridazine
|
572910-56-6
|
C7H7N3
|
|
6-Chloro-imidazo[1,2-b]pyridazine-2-carboxylic acid, methyl ester
|
572910-59-9
|
C8H6ClN3O2
|
|
Imidazo[1,2-a]pyrazin-8(7H)-one, 3-hydroxy-2-methyl- (9CI)
|
572910-67-9
|
C7H7N3O2
|
|
Imidazo[1,2-a]pyrazine, 3-nitroso- (9CI)
|
572910-75-9
|
C6H4N4O
|
|
Imidazo[1,2-a]pyrazine, 5-methoxy- (9CI)
|
572910-76-0
|
C7H7N3O
|
|
Imidazo[1,5-a]pyrimidin-4(1H)-one, 2-methyl- (9CI)
|
572910-80-6
|
C7H7N3O
|
|
1H-Azepine-2,4(3H,5H)-dione,dihydro-1-methyl-(9CI)
|
572911-11-6
|
C7H11NO2
|
|
1H-Azepine-2,4(3H,5H)-dione,dihydro-1-(1-methylethyl)-(9CI)
|
572911-13-8
|
C9H15NO2
|
|
Ethyl 6-[(2-Cyanoethoxy)(4,4-diphenylcyclohexyloxy)phosphoryloxy]hexanoate
|
572913-59-8
|
C29H38NO6P
|
|
3,6-Benzofurandiol (9CI)
|
572916-04-2
|
C8H6O3
|
|
4-Pyrimidinecarboxylicacid,5-ethoxy-1,2,3,6-tetrahydro-1-methyl-2,6-dioxo-(9CI)
|
572917-55-6
|
C8H10N2O5
|
|
2-Imidazolidinone,1-(3-methyl-5-isoxazolyl)-(9CI)
|
572922-65-7
|
C7H9N3O2
|
|
2,4(1H,3H)-Pyrimidinedione, 5,6-diamino-1-(1,1-dimethylethyl)-3-methyl- (9CI)
|
572922-76-0
|
C9H16N4O2
|
|
2,4(1H,3H)-Pyrimidinedione, 5,6-diamino-3-methyl-1-(1-methylpropyl)- (9CI)
|
572922-77-1
|
C9H16N4O2
|
|
(S)-4-Methyl-3-(4-trifluoromethylphenyl)oxazolidin-2-one
|
572922-96-4
|
C11H10F3NO2
|
|
(S)-4-Ethyl-3-phenyloxazolidin-2-one
|
572922-97-5
|
C11H13NO2
|
|
(S)-4-(4-Ethyl-2-oxooxazolidin-3-yl)benzaldehyde
|
572922-98-6
|
C12H13NO3
|
|
(S)-4-(2-Oxo-4-phenyloxazolidin-3-yl)benzaldehyde
|
572922-99-7
|
C16H13NO3
|
|
(S)-4-(4-Isopropyl-2-oxooxazolidin-3-yl)benzaldehyde
|
572923-00-3
|
C13H15NO3
|
|
(S)-4-Ethyl-3-(3-methoxyphenyl)oxazolidin-2-one
|
572923-01-4
|
C12H15NO3
|
|
(S)-3-(3-Methoxyphenyl)-4-phenyloxazolidin-2-one
|
572923-03-6
|
C16H15NO3
|
|
(S)-4-Phenyl-3-p-tolyloxazolidin-2-one
|
572923-05-8
|
C16H15NO2
|
|
(S)-4-Ethyl-3-p-tolyloxazolidin-2-one
|
572923-06-9
|
C12H15NO2
|
|
(S)-4-Ethyl-3-(4-methoxyphenyl)oxazolidin-2-one
|
572923-07-0
|
C12H15NO3
|
|
(S)-4-(4-Ethyl-2-oxooxazolidin-3-yl)benzonitrile
|
572923-10-5
|
C12H12N2O2
|
|
(S)-4-Ethyl-3-(4-nitrophenyl)oxazolidin-2-one
|
572923-12-7
|
C11H12N2O4
|
|
(S)-4-(4-Ethyl-2-oxooxazolidin-3-yl)benzoic acid methyl ester
|
572923-13-8
|
C13H15NO4
|
|
(S)-3-(3-Acetylphenyl)-4-ethyloxazolidin-2-one
|
572923-14-9
|
C13H15NO3
|
|
(S)-2-(4-Ethyl-2-oxooxazolidin-3-yl)benzonitrile
|
572923-15-0
|
C12H12N2O2
|
|
(S)-4-(4-Ethyl-2-oxooxazolidin-3-yl)-N-propylbenzamide
|
572923-16-1
|
C15H20N2O3
|
|
(S)-4-(2-Oxo-4-phenyloxazolidin-3-yl)-N-propylbenzamide
|
572923-17-2
|
C19H20N2O3
|
|
(S)-3-(4-Acetylphenyl)-4-ethyloxazolidin-2-one
|
572923-18-3
|
C13H15NO3
|
|
(S)-3-(4-Acetylphenyl)-4-isopropyloxazolidin-2-one
|
572923-19-4
|
C14H17NO3
|
|
(S)-3-(4-Acetylphenyl)-4-phenyloxazolidin-2-one
|
572923-21-8
|
C17H15NO3
|
|
(S)-2-(4-Trifluoromethylphenylamino)propan-1-ol
|
572923-22-9
|
C10H12F3NO
|
|
(S)-4-(1-Hydroxymethyl-propylamino)benzaldehyde
|
572923-24-1
|
C11H15NO2
|
|
(S)-4-(2-Hydroxy-1-phenyl-ethylamino)benzaldehyde
|
572923-25-2
|
C15H15NO2
|
|
(S)-2-Phenyl-2-p-tolylamino-ethanol
|
572923-26-3
|
C15H17NO
|
|
(S)-2-p-Tolylamino-butan-1-ol
|
572923-27-4
|
C11H17NO
|
|
(S)-2-(4-Methoxyphenylamino)butan-1-ol
|
572923-28-5
|
C11H17NO2
|
|
(S)-4-(1-Hydroxymethyl-propylamino)benzonitrile
|
572923-29-6
|
C11H14N2O
|
|
(S)-2-(4-Nitrophenylamino)butan-1-ol
|
572923-31-0
|
C10H14N2O3
|
|
(S)-1-[4-(1-Hydroxymethylpropylamino)phenyl]ethanone
|
572923-32-1
|
C12H17NO2
|
|
(S)-2-Cyclopentyloxycarbonylamino-3,3-dimethyl-butyric acid
|
572924-00-6
|
C12H21NO4
|
|
42-(Dimethylphosphinate)rapamycin
|
572924-54-0
|
C53H84NO14P
|
|
GenBank CD800910
|
573181-44-9
|
C7H3BrClN
|
|
ANTI-THOMSEN-FRIEDENREICH CARCINOMA ANTIGEN PEPTIDE P30-1
|
573664-50-3
|
C94H130N26O19
|
|
BOMBINAKININ-GAP
|
573671-91-7
|
C145H219N39O39S3
|
|
2-Pyridinecarboxylic acid, 4-[4-[[[[4-chloro-3-(trifluoroMethyl)phenyl]aMino]carbonyl]aMino]phenoxy]-, Methyl ester
|
573673-43-5
|
C21H15ClF3N3O4
|
|
2-[(5Z)-5-(4-fluorobenzylidene)-4-oxo-2-thioxo-1,3-thiazolidin-3-yl]butanedioic acid
|
573673-95-7
|
C14H10FNO5S2
|
|
1-Naphthalenecarboxylic acid, 4-hydroxyphenyl ester
|
573674-19-8
|
C17H12O3
|
|
5-Bromo-3-nitropyridine-2-carbonitrile
|
573675-25-9
|
C6H2BrN3O2
|
|
3-Amino-5-bromo-pyridine-2-carbonitrile
|
573675-27-1
|
C6H4BrN3
|
|
7-Bromopyrido[3,2-d]pyrimidin-4(3H)-one
|
573675-29-3
|
C7H4BrN3O
|
|
7-bromo-4-chloropyrido[3,2-d]pyrimidine
|
573675-31-7
|
C7H3BrClN3
|